Monday, September 14, 2026

US EV Cancellations Rise, K Battery Damage Becomes Reality, Stakes On Price Competitiveness

U.S. EV subsidy cuts disrupt K-Battery industry, forcing manufacturers to lower costs as Ford shifts focus to hybrids.

9-Year-Old Siamese Cat’s Life-Saving Surgery: How a Massive Tumor Was Successfully Removed

A 9-year-old cat named Tini underwent successful surgery to remove a massive stomach tumor, now recovering with chemotherapy.

North Korea’s Advancing AI: Potential Tool for Psychological Warfare and Human Rights Violations

North Korea's AI advancements could be used for disinformation, surveillance, and military applications, prompting calls for sanctions.

Tag: FDA approval

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

SCARLET PRO vs. SB-49TIP: Which FDA-Approved RF Device Will Transform Your Skincare Routine?

Viol Medical has received FDA 510(k) approval for its medical devices, SCARLET PRO and SB-49TIP, enhancing its market presence.

Zamenix P: The First AI-Driven Kidney Stone Surgery Robot Approved by FDA – A Game Changer in Minimally Invasive Surgery?

ROEN Surgical secures FDA approval for its kidney stone surgery robot, targeting the U.S. medical device market.

GC Biopharma Targets Full Utilization of Plasma Centers with FDA Approval of ABO Plasma

GC Biopharma's ABO Plasma gains FDA approval for its Laredo center, enhancing plasma sourcing and operational efficiency ahead of schedule.

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

J&J Aims to Treat Cancer Before It Starts Showing Symptoms

Johnson & Johnson leads in multiple myeloma treatment, pioneering early intervention for high-risk patients with a new subcutaneous formulation.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

FDA Greenlights CMG’s Film-Based Schizophrenia Medication ‘Mezofy’

CMG Pharmaceutical gains FDA approval for Mezofy, a unique oral film for schizophrenia, marking a milestone for South Korean pharma.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.